Stay updated with breaking news from Tom Beer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggressive cancers and those with no standard-of-care screening test1 ...
Robert Taylor Jr. passed away. This is the full obituary where you can share condolences and memories. Published in the The Daily Item on 2023-12-19.
Closing out their panel, experts discuss the potential of blood-based tests to democratize access to cancer screening, complement existing protocols, and achieve early detection goals in the fight against cancer.
Elizabeth O’Donnell, MD, and Tomasz Beer, MD, FACP, recap key takeaways from the panel and consider the potential of MCED testing in transforming cancer screening and addressing gaps in early detection.
The release is their first new music in over a year.